Melbourne, Australia; 17 September 2020: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that a pre-recorded presentation by Dr Jackie Fairley, CEO, will be broadcast on Thursday 17 September 2020 (US ET) as part of OTCQX’s Life Sciences Investor Forum. The forum is one of the largest online investor conference series dedicated to the Life Sciences industry, with more than 72,000 attendees registered, including individual and institutional investors, as well as advisors and analysts.

Details of the forum are found via this link: Virtual Life Sciences Investor Forum - September 17, 2020. Starpharma’s presentation features an overview of the business for new investors, including the recent development update on the SPL7013 COVID-19 nasal spray, and information on the Company’s DEP^® candidates and partnerships, and commercial progress with the VivaGel^® portfolio. The presentation is attached and also available on Starpharma’s website.

The slide presentation is available here (pdf file, 3.5MB)

Download ASX Announcement: Starpharma to present at OTCQX Life Sciences Investor Forum (pdf file, 3.5MB)